Cardiovascular Disease Measures Cluster Group

1
Cardiovascular Disease Measures Cluster Group

• Co-Chairs
• Heather Rickertsen, PharmD
• Title
• Stephen Kogut, PhD, MBA RPh
• Associate Professor and Chair, Department of
  Pharmacy Practice, Univ. of RI
• Members
• Scott Conry, PharmD
• Tasha Michaels. PharmD
• Jennifer Oh, PharmD, MS, BCPS
• Valentine Pascale, PharmD
• Mark Peters, PharmD
• Steven Riddle, PharmD
• Suzanne Roland, PharmD
• Sunil Sinha, MD, MBA
• Craig Stern, PharmD, MBA

2
Measure Concepts

• Rate of use of drugs for dyslipidemia in coronary
  artery disease
• INR monitoring at least monthly
• Avoidance of chronic NSAID use in heart failure
• Avoidance of thiazoladinedione drugs in heart
  failure
• Lipid monitoring in coronary artery disease

3
Use of Drugs for Dyslipidemia in CAD
4
INR Monitoring
5
Avoidance of Chronic NSAID use in HF
6
Avoidance of Thiazolidinedione Drugs in HF
7
Lipid Monitoring in CAD